A mammalian microRNA expression atlas based on small RNA library sequencing P Landgraf, M Rusu, R Sheridan, A Sewer, N Iovino, A Aravin, S Pfeffer, ... Cell 129 (7), 1401-1414, 2007 | 4571 | 2007 |
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 S Hacein-Bey-Abina, A Garrigue, GP Wang, J Soulier, A Lim, E Morillon, ... The Journal of clinical investigation 118 (9), 3132-3142, 2008 | 2275 | 2008 |
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2002* | 2020 |
The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1489 | 2018 |
New microRNAs from mouse and human M Lagos-Quintana, R Rauhut, J Meyer, A Borkhardt, T Tuschl Rna 9 (2), 175-179, 2003 | 1434 | 2003 |
High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma M Metzler, M Wilda, K Busch, S Viehmann, A Borkhardt Genes, Chromosomes and Cancer 39 (2), 167-169, 2004 | 866 | 2004 |
Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots KB Gale, AM Ford, R Repp, A Borkhardt, C Keller, OB Eden, MF Greaves Proceedings of the National Academy of Sciences 94 (25), 13950-13954, 1997 | 695 | 1997 |
Phase I/phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia A von Stackelberg, F Locatelli, G Zugmaier, R Handgretinger, TM Trippett, ... Journal of Clinical Oncology 34 (36), 4381-4389, 2016 | 630 | 2016 |
Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi) M Wilda, U Fuchs, W Wössmann, A Borkhardt Oncogene 21 (37), 5716-5724, 2002 | 612 | 2002 |
Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy T Tuschl, A Borkhardt Molecular Interventions 2 (3), 158, 2002 | 518 | 2002 |
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing Nature genetics 44 (12), 1316-1320, 2012 | 505 | 2012 |
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia M Dördelmann, A Reiter, A Borkhardt, WD Ludwig, N Götz, ... Blood, The Journal of the American Society of Hematology 94 (4), 1209-1217, 1999 | 463 | 1999 |
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing V Hovestadt, DTW Jones, S Picelli, W Wang, M Kool, PA Northcott, ... Nature 510 (7506), 537-541, 2014 | 461 | 2014 |
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM … P Bader, H Kreyenberg, GHR Henze, C Eckert, M Reising, A Willasch, ... Journal of Clinical Oncology 27 (3), 377-384, 2009 | 448 | 2009 |
RNA targets of wild-type and mutant FET family proteins JI Hoell, E Larsson, S Runge, JD Nusbaum, S Duggimpudi, TA Farazi, ... Nature structural & molecular biology 18 (12), 1428-1431, 2011 | 418 | 2011 |
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report … L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ... Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010 | 410 | 2010 |
Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization BB Zeisig, T Milne, MP García-Cuéllar, S Schreiner, ME Martin, U Fuchs, ... Molecular and cellular biology 24 (2), 617-628, 2004 | 409 | 2004 |
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ... The Lancet 372 (9648), 1484-1492, 2008 | 408 | 2008 |
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials A Borkhardt, G Cazzaniga, S Viehmann, MG Valsecchi, WD Ludwig, ... Blood, The Journal of the American Society of Hematology 90 (2), 571-577, 1997 | 403 | 1997 |
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU B Neven, I Callebaut, AM Prieur, J Feldmann, C Bodemer, L Lepore, ... Blood 103 (7), 2809-2815, 2004 | 374 | 2004 |